Zoetis Inc. (NYSE:ZTS) Shares Sold by Tritonpoint Wealth LLC

Tritonpoint Wealth LLC decreased its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 6.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 32,989 shares of the company's stock after selling 2,214 shares during the quarter. Tritonpoint Wealth LLC's holdings in Zoetis were worth $5,375,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ZTS. Darwin Wealth Management LLC purchased a new stake in Zoetis during the third quarter valued at $31,000. First Personal Financial Services purchased a new stake in Zoetis during the third quarter valued at $33,000. Capital Performance Advisors LLP purchased a new stake in Zoetis during the third quarter valued at $33,000. Dunhill Financial LLC raised its stake in Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company's stock valued at $33,000 after purchasing an additional 75 shares in the last quarter. Finally, Quarry LP raised its stake in Zoetis by 273.2% during the second quarter. Quarry LP now owns 209 shares of the company's stock valued at $36,000 after purchasing an additional 153 shares in the last quarter. Institutional investors own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ZTS. Leerink Partnrs raised shares of Zoetis to a "strong-buy" rating in a research note on Monday, December 2nd. Morgan Stanley reduced their target price on shares of Zoetis from $248.00 to $243.00 and set an "overweight" rating on the stock in a research note on Wednesday, January 29th. Stifel Nicolaus reduced their target price on shares of Zoetis from $210.00 to $180.00 and set a "buy" rating on the stock in a research note on Tuesday, January 7th. UBS Group began coverage on shares of Zoetis in a research note on Monday, December 9th. They issued a "neutral" rating and a $196.00 target price on the stock. Finally, JPMorgan Chase & Co. increased their target price on shares of Zoetis from $225.00 to $230.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $215.00.

Zoetis Stock Up 0.2 %

Zoetis stock traded up $0.30 during midday trading on Tuesday, hitting $172.24. 2,696,175 shares of the company's stock were exchanged, compared to its average volume of 2,685,644. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53. The firm has a 50-day moving average of $169.48 and a two-hundred day moving average of $179.39. The company has a market cap of $77.71 billion, a PE ratio of 32.38, a P/E/G ratio of 2.72 and a beta of 0.90.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts' consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion for the quarter, compared to analysts' expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company's revenue was up 11.6% compared to the same quarter last year. During the same period last year, the business earned $1.36 EPS. As a group, analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This is a positive change from Zoetis's previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a yield of 1.16%. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis's payout ratio is currently 37.59%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.